The ability to alter proteins to refine control over binding affinity and specificity can create tailored therapeutics with reduced side effects, highly sensitive diagnostic tools, efficient ...
A paper appeared in International Journal of Pharmaceutics. A team of researchers from Kazan Federal University, Russia, led by Dr. Igor Sedov, reported an application of capillary differential ...
GPCRs (G-protein-coupled receptors) represent the largest family of membrane receptors currently targeted by approved drugs. It is estimated that approximately 700 approved drugs target GPCRs ...
The quantification of proteins is an integral part of biopharmaceutical R&D. From the crude quantitation of hybridoma expression profiles of monoclonal antibodies, to quantitative determination of ...
Development of a methylation-based, tissue-free test for the detection of molecular residual disease by circulating tumor DNA.
Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for ...
(Nanowerk News) An interdisciplinary research team of the Institutes of Physical Chemistry and Physics of the University of Freiburg and the Max Planck Institute of Biophysics in Frankfurt-am-Main has ...
Various approaches to such protein redesign have drawbacks. Traditional methods include time-consuming trial and error efforts, and many models in the emerging field ...
image: A team of researchers from Kazan Federal University, Russia, led by Dr. Igor Sedov, reported an application of capillary differential scanning calorimetry technique for the study of the binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results